Hormone receptor alterations and treatment responses after neoadjuvant therapy in patients with ER+/HER2- breast cancer.

Shigeto Maeda,Hiroaki Tohyama,Yukiko Tokai,Kazuaki Nakashima,Yukio Kamohara,Yasuhiro Nagata,Masahiro Ito,Hikaru Fujioka

Hormone receptor alterations and treatment responses after neoadjuvant therapy in patients with ER+/HER2- breast cancer.

2017

Shigeto Maeda
Hiroaki Tohyama
Yukiko Tokai
Kazuaki Nakashima
Yukio Kamohara
Yasuhiro Nagata
Masahiro Ito
Hikaru Fujioka

e11605 Background: Hormone therapy is recommended for treating patients with luminal A type early breast cancer by the International Conference in St. Gallen, 2011. However, precisely which neoadju...

Keywords:

Hormone receptor
Hormone therapy
Oncology
Pathology
Neoadjuvant therapy
Medicine
Breast cancer
Internal medicine
luminal a
early breast cancer
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations